Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been awarded several contracts by the U.S. Centers for Disease Control and Prevention ...
Thermo Fisher boosted the lower end of its forecast for adjusted 2024 earnings, now anticipating net profit in a range between $21.35 and $22.07 a share, compared with the prior target of ...